These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
202 related items for PubMed ID: 9004813
21. Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies. Huckell VF, Bernstein V, Crowell R, Dagenais GR, Higginson LA, Isserow S, Laramée P, Liu P, McCans JL, Orchard RC, Prewitt R, Quinn BP, Samson M, Turazza F, Warnica JW, Wielgosz A. Can J Cardiol; 1997 Feb; 13(2):173-82. PubMed ID: 9070169 [Abstract] [Full Text] [Related]
22. [Diagnostic and therapeutic strategies in post-infarct]. Romano S, Rinaldi E, Fusilli C, Celotto A, Scrimieri P, Penco M. Clin Ter; 2000 Feb; 151(1):37-43. PubMed ID: 10822880 [Abstract] [Full Text] [Related]
23. Applying the results of large clinical trials in the management of acute myocardial infarction. Sweeney JP, Schwartz GG. West J Med; 1996 Mar; 164(3):238-48. PubMed ID: 8775936 [Abstract] [Full Text] [Related]
24. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT). White HD, Aylward PE, Huang Z, Dalby AJ, Weaver WD, Barvik S, Marin-Neto JA, Murin J, Nordlander RO, van Gilst WH, Zannad F, McMurray JJ, Califf RM, Pfeffer MA, VALIANT Investigators. Circulation; 2005 Nov 29; 112(22):3391-9. PubMed ID: 16301343 [Abstract] [Full Text] [Related]
25. Prevention of remodeling of the heart after myocardial infarction. Gorlin R. Mt Sinai J Med; 1995 Sep 29; 62(4):287-92. PubMed ID: 7565851 [Abstract] [Full Text] [Related]
26. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI]. Ferrari R, Papa K, Bernocchi P, Gimbatti OJ, Golcea SS, Bettini A, Ceconi C. Ital Heart J; 2005 Nov 29; 6 Suppl 7():24S-32S. PubMed ID: 16485514 [Abstract] [Full Text] [Related]
27. Medical management after myocardial infarction: an evidence-based perspective. Sharpe N. Br J Clin Pract Suppl; 1996 Jul 29; 84():25-30. PubMed ID: 8994999 [Abstract] [Full Text] [Related]
28. Acute ischemic coronary artery disease and ischemic stroke: similarities and differences. Fisher M, Folland E. Am J Ther; 2008 Jul 29; 15(2):137-49. PubMed ID: 18356634 [Abstract] [Full Text] [Related]
29. [From the great clinical studies to the management of the single patient. Medical therapy in the pre- and post-fibrinolytic era]. Mazzotta G, Piccininno M, Ricci D. Ital Heart J; 2000 Jun 29; 1 Suppl 2():83-92. PubMed ID: 10905134 [Abstract] [Full Text] [Related]
30. Hospital therapy traditions influence long-term survival in patients with acute myocardial infarction. Stenestrand U, Lindbäck J, Wallentin L. Am Heart J; 2005 Jan 29; 149(1):82-90. PubMed ID: 15660038 [Abstract] [Full Text] [Related]
31. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators. Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W. J Cardiovasc Electrophysiol; 2009 Apr 29; 20(4):395-400. PubMed ID: 19017351 [Abstract] [Full Text] [Related]
32. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study. Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators. Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606 [Abstract] [Full Text] [Related]
33. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L. Am Heart J; 2003 Mar 27; 145(3):438-44. PubMed ID: 12660666 [Abstract] [Full Text] [Related]
34. Interventions during and after acute myocardial infarction. Sleight P. Postgrad Med J; 1983 Mar 27; 59 Suppl 3():80-8. PubMed ID: 6139802 [Abstract] [Full Text] [Related]
36. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction. Badano L, Cassin M, Solinas L, Burelli C, Macor F, Zanuttini D. G Ital Cardiol; 1999 Jan 27; 29(1):39-47. PubMed ID: 9987046 [Abstract] [Full Text] [Related]
37. Improving the management of patients after myocardial infarction, from admission to discharge. Amin A. Clin Ther; 2006 Oct 27; 28(10):1509-39. PubMed ID: 17157110 [Abstract] [Full Text] [Related]
38. Potential novel pharmacological therapies for myocardial remodelling. Landmesser U, Wollert KC, Drexler H. Cardiovasc Res; 2009 Feb 15; 81(3):519-27. PubMed ID: 19019834 [Abstract] [Full Text] [Related]
39. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group. Second Chinese Cardiac Study (CCS-2) Collaborative Group. J Cardiovasc Risk; 2000 Dec 15; 7(6):435-41. PubMed ID: 11189013 [Abstract] [Full Text] [Related]
40. [Magnesium sulfate in acute myocardial infarction]. Balli E, Giomi A, Del Citerna F. G Ital Cardiol; 1995 Nov 15; 25(11):1425-32. PubMed ID: 8682239 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]